LB Pharmaceuticals Inc Common Stock (LBRX) NASDAQ
32.74
+0.9089(+2.86%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
32.74
+0.9089(+2.86%)
Currency In USD
Address
One Pennsylvania Plaza
New York, NY 10119
United States of America (the)
Phone
212 605 0300
Website
Sector
Healthcare
Industry
Biotechnology
Employees
16
First IPO Date
September 11, 2025
| Name | Title | Pay | Year Born |
| Zachary Prensky | Co-founder, Advisor to the Chief Executive Officer & Director | 13,716 | 1976 |
| Heather D. Turner | Chief Executive Officer & Director | 1.02M | 1973 |
| Anna Eramo | Chief Medical Officer | 616,933 | 1975 |
| Soffer | Chief Operating & Business Officer | 644,801 | 1977 |
| Richard Silva | Senior Vice President of Technical Operations | 0 | 1968 |
| James Rawls | Senior Vice President of Regulatory Affairs | 0 | N/A |
| Marc L. Panoff | Senior Vice President of Finance | 0 | 1970 |
| Ellen Rose | Senior Vice President of Corporate Affairs | 0 | N/A |
| Kaya Pai Panandiker | Chief Commercial Officer | 0 | 1977 |
| Lindsay Beaupre | Senior VP of People & Culture | 0 | N/A |
| Minako Pazdera | General Counsel | 0 | N/A |
Clinical‑stage biopharmaceutical company developing novel therapies for neuropsychiatric diseases (e.g. schizophrenia, bipolar depression). Lead candidate is LB‑102, a methylated derivative of amisulpride.